June 13, 2018 - The Siemens technology group and Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation. This agreement provides that Sartorius Stedim Biotech will use Siemens automation technologies, which will include industrial PCs, the S7-1500 software controller, the TIA Portal and the SCADA system Simatic WinCC, among others. These hardware and software components will be employed in many products and solutions that SSB offers its customers for the development and manufacture of biopharmaceuticals, such as vaccines and monoclonal antibodies.
To standardize its own product portfolio even further, SSB has decided to introduce a configurable automation system for its range of systems. Under the agreement recently concluded, cooperation between the two companies will therefore be extended to further Sartorius Stedim Biotech products. These will be successively equipped with Siemens automated solutions in the coming months and can thus be integrated into process control systems such as Simatic PCS 7 and Simatic Batch. Essentially, such SSB products are single-use bioreactors of the BIOSTAT STR series, various filtration systems and the FlexAct system. The latter is a flexible module that is used to control many different process steps within biopharmaceutical production.
During this year’s Achema trade show that will be taking place from June 11 to June 15, 2018, in Frankfurt, Germany, Siemens and Sartorius Stedim Biotech will be jointly presenting the FlexAct module. Visitors and all others interested are cordially invited to obtain first-hand information at the Siemens AG booth in Hall 11/C3. A presentation on this product